MC

701.9

+0.8%↑

SAF

244

-1.69%↓

MUV2

513.6

-0.35%↓

KBC

81.2

+0.35%↑

PUB

102.75

+0.69%↑

MC

701.9

+0.8%↑

SAF

244

-1.69%↓

MUV2

513.6

-0.35%↓

KBC

81.2

+0.35%↑

PUB

102.75

+0.69%↑

MC

701.9

+0.8%↑

SAF

244

-1.69%↓

MUV2

513.6

-0.35%↓

KBC

81.2

+0.35%↑

PUB

102.75

+0.69%↑

MC

701.9

+0.8%↑

SAF

244

-1.69%↓

MUV2

513.6

-0.35%↓

KBC

81.2

+0.35%↑

PUB

102.75

+0.69%↑

MC

701.9

+0.8%↑

SAF

244

-1.69%↓

MUV2

513.6

-0.35%↓

KBC

81.2

+0.35%↑

PUB

102.75

+0.69%↑

Search

Eurazeo SE

Cerrado

Sector Finanzas

79.95 0.63

Resumen

Variación precio

24h

Actual

Mínimo

79.95

Máximo

80.1

Métricas clave

By Trading Economics

Ingresos

-105M

Ventas

104M

Rentabilidad por dividendo

3

Margen de beneficio

-100.723

Empleados

410

EBITDA

-51M

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

3.00%

3.82%

Próximas Ganancias

6 mar 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

5.6B

Apertura anterior

79.32

Cierre anterior

79.95

Noticias sobre sentimiento de mercado

By Acuity

18%

82%

41 / 545 Clasificación en Finance

Puntuación técnica

By Trading Central

Confianza

Weak Bullish Evidence

Eurazeo SE Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

11 sept 2024, 06:28 UTC

Adquisiciones, fusiones, absorciones

EQT Leads $102.5 Million Series A Funding Round in Belgian Radioisotope Producer PanTera

Comparación entre iguales

Cambio de precio

Eurazeo SE Esperado

Consenso

By TipRanks

0 ratings

0

Comprar

0

Mantener

0

Vender

Puntuación técnica

By Trading Central

79 / 80.05Soporte y Resistencia

Corto Plazo

Weak Bullish Evidence

Medio plazo

Strong Bullish Evidence

Largo Plazo

Strong Bullish Evidence

Sentimiento

By Acuity

41 / 545 Clasificación en Finanzas

Noticias sobre sentimiento de mercado

Coyuntura alcista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Eurazeo SE

Eurazeo SE is a private equity and venture capital firm specializing in growth capital, acquisitions, leveraged buyouts, and buy-ins of a private company, and investments in mid-market and listed public companies. The company invest in equity in the small-mid and Mid-large buyout segments. The firm seeks to invest in medium-sized or large companies, SMEs, high growth companies, and real estate management and investment activities. It does not have any restrictions regarding the sectors in which it invests but prefers to invest in smart cities, services, leisure and mobility, real estate, fintech, investment activities, distribution, industry, luxury, consumer goods, business services, consumer and retail brands, and health sectors. The firm seeks to invest in consumer brands with a focus on beauty, personal care, household care, juvenile products, apparel, wellness, accessories, home, jewellery, leisure, health, fitness, beverage, and food companies based in United States and Europe. It typically invests in companies with a differentiated concept and global growth potential. The firm identifies companies upstream, carefully selecting them primarily from sectors driven by digital transformation and focusing on changes in lifestyle and consumption (mobility, online buying, collaboration models, etc. The firm invests in large properties in need of restructuring; residential, commercial, and office development projects; and companies with real estate assets in Western Europe. It primarily invests in United States, France, Italy, North America and other European countries. It seeks to invest between "50 million ($54.35 million) to "250 million ($271.77 million) in small mid buyout business. It seeks to invest between "25 million ($27.18 million) to "100 million ($108.71 million) in growth business. It seeks to invest between "10 million ($10.82 million) and "40 million ($43.82 million) in the fields of healthcare research. It seeks to invests between equity investment between "1 million ($1.17 million) and "559.01 mil